Published in Circ Res on November 01, 1986
Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest (1992) 1.04
Heat production of quiescent ventricular trabeculae isolated from guinea-pig heart. J Physiol (1988) 0.97
Interventricular comparison of the energetics of contraction of trabeculae carneae isolated from the rat heart. J Physiol (2012) 0.85
Uniformity of calcium channel number and isometric contraction in human right and left ventricular myocardium. Basic Res Cardiol (1994) 0.85
Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. Br J Pharmacol (1996) 0.85
Do right-ventricular trabeculae gain energetic advantage from having a greater velocity of shortening? J Physiol (2017) 0.75
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation (1994) 2.74
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med (1992) 2.72
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol Cell Biol (1999) 1.95
Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med (2001) 1.93
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J (2000) 1.88
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol (1990) 1.66
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation (1998) 1.63
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Circulation (1982) 1.54
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J (1998) 1.52
Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy. Chest (1989) 1.52
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. Can J Cardiol (2003) 1.49
Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Circulation (1998) 1.45
Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med (2001) 1.39
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation (1995) 1.26
Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation (2001) 1.23
Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem (2001) 1.22
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res (1991) 1.22
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol (2001) 1.21
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol Cell Biol (2001) 1.14
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol (1997) 1.14
Assessment of psychosocial functioning of patients with sickle cell disease. South Med J (1988) 1.12
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am Heart J (2001) 1.09
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation (1997) 1.08
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06
Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarction. Am J Cardiol (1997) 1.04
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides (2000) 1.04
Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol (1998) 1.04
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J (2000) 1.02
Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation (1997) 1.02
Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation (1997) 1.01
Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol (1983) 1.01
Variants of preexcitation--specialized atriofascicular pathways, nodofascicular pathways, and fasciculoventricular pathways: electrophysiologic findings and target sites for radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1996) 1.01
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology (1999) 1.01
Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol (1994) 1.00
Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect. Circulation (1985) 0.99
Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med (1988) 0.99
High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol Biol Phys (1996) 0.98
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol (1999) 0.96
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity. Circulation (1986) 0.96
Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol (1991) 0.96
Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol (1994) 0.96
Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol (1984) 0.96
Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J (1988) 0.95
Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation (1992) 0.94
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Role of endocardial endothelium. Circ Res (1991) 0.90
Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure. Br Heart J (1982) 0.89
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol (1994) 0.89
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol (1995) 0.89
Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol (1989) 0.89
A health perception score predicts cardiac events in patients with heart failure: results from the IMPRESS trial. J Card Fail (2001) 0.88
Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts. Circulation (1999) 0.86
GATA4 mediates activation of the B-type natriuretic peptide gene expression in response to hemodynamic stress. Endocrinology (2001) 0.86
Spontaneous abortions during the second trimester of gestation. Arch Pathol Lab Med (1993) 0.86
Age- and gender-related changes in endothelin and catecholamine release, and in autonomic balance in response to head-up tilt. Clin Sci (Lond) (1997) 0.85
The importance of microalbuminuria as a cardiovascular risk indicator: A review. Can J Cardiol (2002) 0.85
Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. Circulation (1998) 0.85
Prazosin and congestive heart failure: short- and long-term therapy. Am J Med (1981) 0.84
Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost. Am Heart J (1982) 0.84
The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol (1993) 0.84
Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster. Circ Res (1982) 0.83
Multiple paraphilic diagnoses among sex offenders. Bull Am Acad Psychiatry Law (1988) 0.83
Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol (1987) 0.83
Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with right bundle branch block, left axis morphology. Pacing Clin Electrophysiol (1993) 0.83
Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat : effects of ramipril and hydralazine. Circulation (1998) 0.83
Functional and morphological characteristics of compensated and decompensated cardiac hypertrophy in dogs with chronic infrarenal aorto-caval fistulas. Circ Res (1990) 0.82
Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure. Am Heart J (1985) 0.82
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. Am Heart J (2001) 0.82
Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat: importance of timing. Circulation (2001) 0.82
Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant (2009) 0.82
Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. Am Heart J (1990) 0.82
Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure. Br Heart J (1986) 0.81
Bradykinin metabolism and hypotensive transfusion reactions. Transfusion (2001) 0.81
Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. Circ Res (1993) 0.81
The effect of captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease. Postgrad Med J (1986) 0.81
The cardiac endothelium: functional morphology, development, and physiology. Prog Cardiovasc Dis (1997) 0.81
Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction. Biochem Cell Biol (1992) 0.81
Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol (1999) 0.81
Acute effects of captopril on the coronary circulation of patients with hypertension and angina. Am J Med (1984) 0.81
Bradykinin metabolism in the postinfarcted rat heart: role of ACE and neutral endopeptidase 24.11. Am J Physiol (1999) 0.81
How to digitalize and to maintain optimal digoxin levels in congestive heart failure. Cardiovasc Drugs Ther (1989) 0.80
Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat. Can J Physiol Pharmacol (1998) 0.80